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Abstract
Background: Idiopathic inflammatory myopathy (IIM) is a group of autoimmune diseases with systemic myositis
which may involve the myocardium. Cardiac involvement in IIM, although often subclinical, may mimic clinical
manifestations of acute viral myocarditis (AVM). Our aim was to investigate the usefulness of the combined analysis
of cardiovascular magnetic resonance (CMR) T1 and T2 mapping parameters measured both in the myocardium
and in the thoracic skeletal muscles to differentiate AVM from IIM cardiac involvement.
Methods: Sixty subjects were included in this retrospective study (36 male, age 45 ± 16 years): twenty patients with
AVM, twenty patients with IIM and cardiac involvement and twenty healthy controls. Study participants underwent
CMR imaging with modified Look-Locker inversion-recovery (MOLLI) T1 mapping and 3-point balanced steady-
state-free precession T2 mapping. Relaxation times were quantified after endocardial and epicardial delineation on
basal and medial short-axis slices, as well as in different thoracic skeletal muscle groups present in the CMR field-of-
view. ROC-Analysis was performed to assess the ability of mapping indices to discriminate the study groups.
Results: Mapping parameters in the thoracic skeletal muscles were able to discriminate between AVM and IIM
patients. Best skeletal muscle parameters to identify IIM from AVM patients were reduced post-contrast T1 and
increased extracellular volume (ECV), resulting in an area under the ROC curve (AUC) of 0.95 for post-contrast T1
and 0.96 for ECV. Conversely, myocardial mapping parameters did not discriminate IIM from AVM patients but
increased native T1 (AUC 0.89 for AVM; 0.84 for IIM) and increased T2 (AUC 0.82 for AVM; 0.88 for IIM) could
differentiate both patient groups from healthy controls.
Conclusion: CMR myocardial mapping detects cardiac inflammation in AVM and IIM compared to normal myocardium
in healthy controls but does not differentiate IIM from AVM. However, thoracic skeletal muscle mapping was able to
accurately discern IIM from AVM.
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Background
Myocarditis is commonly defined as an inflammatory in-
jury to the myocardium that may result from a variety of
causes, most frequently acute viral infection but also sys-
temic inflammatory disease. Idiopathic inflammatory
myopathy (IIM) is a group of chronic autoimmune sys-
temic myositis, including polymyositis, dermatomyositis
and inclusion body myositis [1]. Clinical presentation in-
cludes proximal muscle weakness, myalgia, dysphagia
and dyspnea related to respiratory muscle dysfunction
and/or interstitial lung disease [2]. Skeletal muscle in-
volvement in IIM may be associated to inflammatory
myocardial involvement [3]. When diagnosed, these
disorders may be treated with glucocorticoids and im-
munosuppressive therapy to reduce muscular inflamma-
tion and restore muscular performance [4]. Autopsy series
have shown histology proven myocarditis to be present in
25% to 30% of patients with IIM [5, 6] and single-photon
emission computed tomography (SPECT) studies have
demonstrated increased myocardial Technetium-99 m-
Pyrophosphate-uptake in 57% of patients with dermato-
myositis and polymyositis [7]. Moreover, myocarditis
related to IIM requires intensified and prolonged im-
munosuppression [8] and is the most common cause of
adverse outcome and death in IIM [2]. Many occur-
rences may remain subclinical, but when symptomatic,
cardiac symptoms in IIM are similar to acute viral myo-
carditis (AVM) and include heart failure, arrhythmia
and chest pain [9], associated to troponin elevation. In
addition, these patients are at increased risk of coronary
artery spasm and microvascular disease due to IIM-
related vasculitis [10].
Cardiovascular magnetic resonance (CMR) T2-weighted
and late gadolinium enhancement (LGE) sequences allow
for non-invasive detection of myocarditis in 50% of pa-
tients with a troponin-positive episode of chest pain and
absence of coronary artery disease. However, the under-
lying etiology remains unclear in 35% of these cases [11].
New CMR parametric mapping techniques allow to quan-
tify myocardial relaxation times [12] and challenge the ori-
ginal Lake Louise criteria [13], particularly native T1
mapping and extracellular volume fraction (ECV), which
were shown to be sensitive markers of myocardial in-
volvement in AVM [14, 15]. Reports of non-invasive
characterization of IIM in CMR are scarce. One recent
case report showed increased native T1, T2 and T1-
derived ECV in one patient with antisynthetase syn-
drome [16]. Several peripheral muscle investigations
were performed in IIM patients using magnetic reson-
ance aimed at edema detection [17], including a few
studies with quantitative analysis of peripheral muscle
edema using T2 mapping [18].
Our study aims to investigate the usefulness of com-
bined T1 and T2 mapping in cardiac and skeletal
muscles as a novel approach to differentiate IIM from
AVM in the clinical setting.
Methods
Study population
For this retrospective study, a total of 60 participants
were included (36 male, 45 ± 16 years): 20 consecutive
patients with AVM, 20 consecutive patients with IIM
and 20 healthy subjects. AVM patients were included
based on clinical guidelines and presented with recent
onset chest pain, elevated troponin T and C-reactive
protein (CRP), as well as absence of coronary artery dis-
ease on angiography, performed in case of acute coron-
ary syndrome-like clinical presentation. Patients without
cardiac troponin > 50 ng/ml or with onset of symptoms
> 2 weeks before CMR or with prior myocardial infarc-
tion were excluded. IIM patients were included based on
the elevation of skeletal muscle enzyme levels, evidence
of myositis on skeletal muscle biopsy, electromyography
(EMG) features of myositis and elevated cardiac tropo-
nins > 50 ng/ml at the time of CMR indicating cardiac
involvement. Patients with > 2 weeks between troponin
elevation and CMR, or with fever or flu-like syndrome
in the past 6 months were excluded. Electrocardiogram
(ECG) ST-elevation on admission was found in 9/20 of
the AVM patients and 4/20 of the IIM patients and led
to immediate coronary angiography to assess for coron-
ary artery disease. In addition, 20 asymptomatic subjects
without personal medical history or overt cardiovascular
disease and normal clinical exam underwent CMR as
healthy controls. The study was approved by the local
ethics committee and written informed consent was ob-
tained from all participants. The following laboratory
test results were collected: hematocrit, NT-proBNP
(pg/ml), troponin T (ng/ml), creatine phosphokinase
(CPK, IU/l) and CRP(mg/l). The delay between CMR
and blood sampling was 4 ± 6 days in IIM patients and
1 ± 1 days in AVM patients. Blood sampling for the
control group was performed at the time of CMR. Gen-
der, age, body mass index (BMI) and cardiovascular risk
factors were collected. Heart failure was defined by the
presence of typical symptoms including breathlessness,
fatigue accompanied by signs of elevated right and/or
left filling pressures: dilated jugular veins, lower extremity
edema, pulmonary edema and/or effusion. Studied IIM
patients included: 7 necrotizing autoimmune myopathies,
5 anti-synthetase and 2 overlap syndromes, 3 polymyositis,
2 dermatomyositis and 1 inclusion body myositis.
CMR protocol
All participants had CMR on a 1.5T magnet (Magnetom
Aera, Siemens Healthineers, Erlangen, Germany) with
the following acquisition sequences: 1) balanced steady
state free precession (bSSFP) cine imaging in short- and
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long-axis views with typical parameters: acquisition
matrix = 216 × 256, repetition time = 51 ms, echo time =
1.19 ms, flip angle = 53°, pixel size = 1.48 × 1.48mm2,
slice thickness = 6 mm, inter-slice gap = 1 mm. Temporal
resolution was between 10 and 40 ms; 2) short- and
long-axis LGE sequences acquired with a single shot in-
version recovery sequence 7 to 10 min after injection of
0.2 mmol/kg of gadobenate dimeglumine (Multihance,
Bracco, Milan, Italy) with the following parameters: ac-
quisition matrix = 240 × 240, inversion time individually
chosen on TI scout, repetition time = 347 ms, echo
time = 1.18 ms, flip angle = 40°, pixel size = 1.46 ×
1.46mm2, slice thickness = 8 mm, inter-slice gap =
0.8 mm; 3) Motion-corrected basal, mid-LV and apical
short-axis Look-Locker inversion-recovery (MOLLI) T1
mapping sequence with a 5(3)3 scheme before and
15 min after intravenous contrast agent injection with
the following parameters: acquisition matrix = 218 ×
256, echo time = 1.12 ms, repetition time = 343.86 ms,
flip angle = 35°, pixel size = 1.41 × 1.41mm2, slice thick-
ness = 8 mm; 4) T2 mapping was performed in basal,
mid-LV and apical short-axis slices using a 3-point T2-
prepared bSSFP sequence before contrast injection with
the following CMR parameters: acquisition matrix =
206 × 256, echo time = 0,24,55 ms, repetition time =
299.74 ms, flip angle = 35°, pixel size = 1.41 × 1.41mm2,
slice thickness = 8 mm.
CMR assessment of cardiac volumes, function and LGE
Left ventricular (LV) and right ventricular (RV) volumes
and ejection fraction (EF) as well as LV mass have been
assessed based on standard short axis semi-automated
endocardial and epicardial segmentation. Feature
tracking was used to calculate LV and RV myocardial
global longitudinal strain (GLS), averaged from 2
chamber and 4 chamber long axis cine views with a
dedicated semi-automated software, as previously de-
scribed [19]. Longitudinal strains were defined as sys-
tolic peaks of the temporal curves of myocardial
length. For the RV, the lateral wall was used for strain
analysis, since the septum is strongly influenced by LV
function. The number of segments with LGE were
noted for each patient according to the American
Heart Association (AHA) 17-segments model.
CMR mapping
Endocardial and epicardial contours were traced with
motion-correction for every single TI-image on MOLLI
images to exclude near wall blood, epicardial fat or areas
presenting Gibbs artifacts. T1 maps were then calculated
on basal and mid-LV short-axis slices for both native
and post contrast images. Apical slices were not ana-
lyzed, due to higher prevalence of motion artifacts and
risk of partial volume effect caused by obliquity and
thinner wall. Myocardium was automatically segmented
into AHA segments using the anterior right septal inser-
tion mark as a reference. Whole-heart myocardial relax-
ation times were calculated as the mean of mid-LV and
basal slices, including and excluding LGE-positive seg-
ments. The same analysis was performed for T2 map-
ping. To estimate thoracic muscle T1 and T2 values,
regions of interest (ROI) were traced and adjusted for
every TI or TE-image on each of the following skeletal
muscles, if identified in the acquired field of view: pec-
toralis major, subscapularis, infraspinatus, upper arm
and erector spinae muscles. The ROI was drawn on the
first TI/TE-image by excluding perimuscular fat and
intramuscular tendons as illustrated in Fig. 1. For every
Fig. 1 Mapping parameters estimation in the skeletal muscles. As a first step, visible skeletal muscles were delineated on the first TI image after
setting the adequate gray levels. Second, each muscle region of interest (ROI) was propagated on all the following TI images. Third, a zoom was
performed around each propagated ROIs and gray levels were adjusted to allow their reshaping and displacement in order to avoid fat and
vessels as well as to adapt to muscle deformation when necessary. Finally, for each ROI, gray levels were averaged for successive TI images and
the resulting signal is fitted with an exponential model to calculate native T1 in the above example. Of note, this process is performed first on
native T1 dataset and the resulting ROIs are copied on post-contrast T1 and T2 datasets and the correction process is repeated
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subsequent TI/TE image, ROIs were modified and even-
tually shifted in case of muscle movement during image
acquisition. Relaxation times were estimated on a per
muscle basis and averaged over all muscles for each pa-
tient. For both myocardium and skeletal muscles, ECV
was calculated as follows [20]:
ECV ¼ 1‐hematocritð Þ  λ;with
λ ¼
1
T1 tissue post contrast
−
1
T1 tissue native
1
T1 blood pool post contrast
−
1
T1 blood pool native
Statistical analysis
Comparisons between IIM and AVM patients and con-
trols were performed using non-parametric Mann-
Whitney’s test for continuous variables and Fisher’s
Exact Test for categorical variables. For multiple group
comparisons (such as T1 and T2 values in different
muscle locations), non-parametric Kruskal-Wallis test
was used. Receiver operating characteristic (ROC) ana-
lysis was used to determine the most discriminating
mapping parameter and cutoff values. A p-value < 0.05
was regarded as significant. Multivariate analysis was used
including age as a covariate to calculate age-adjusted p-
values for cardiac volumes and mapping indices. Analysis
was performed using GraphPad Prism (Version 7.1,
GraphPad Software Inc., La Jolla, California, USA) and
Stata (Version 11.2, Stata Corporation, College Station,
Texas, USA).
Results
Patient characteristics
Baseline characteristics of the study population are
shown in Table 1. As expected, patients with AVM were
younger and mostly males, while IIM patients were older
and gender was equally distributed. The mean age of
healthy controls fell between the mean age of AVM and
IIM patients. AVM and IIM patients had a similar car-
diovascular risk profiles except for age. Expectedly, IIM
patients had a significantly longer duration of disease
Table 1 Baseline Characteristics of the Study Population
Healthy controls
(n = 20)
Acute viral myocarditis
(n = 20)
IIM with inflammatory
myocarditis
(n = 20)
p - value
Age, years 47 ± 12 35 ± 13* 54 ± 18 < 0.001
Male / Female 9 / 11 16 / 4* 9 / 11 0.048
BMI, kg/m2 25 ± 4 24 ± 6 22 ± 3 0.286
Heart failure 0 (0%) 2 (10%) 1 (5%) > 0.999
Atrial fibrillation or AV block 0 (0%) 4 (20%) 5 (25%)* 0.725
Significant valvulopathy 0 (0%) 0 (0%) 0 (0%)
Dyspnea 0 (0%) 2 (10%) 6 (30%)* 0.235
Chest pain 0 (0%) 19 (95%)* 2 (10%) < 0.001
Dysphagia 0 (0%) 0 (0%) 2 (10%) 0.487
Myalgia 0 (0%) 0 (0%) 7 (35%)* 0.008
Muscle weakness 0 (0%) 0 (0%) 19 (95%)* < 0.001
Arterial hypertension 0 (0%) 3 (15%) 3 (15%)
Dyslipidemia 0 (0%) 2 (10%) 5 (25%) 0.408
Diabetes 0 (0%) 0 (0%) 2 (10%) 0.487
Immunosuppressive treatment 0 (0%) 0 (0%) 20 (100%)* < 0.001
Duration of disease, months 0 ± 0 0.17 ± 0.13 57 ± 53 0.001
NT-proBNP, pg/ml N/A 1636 ± 3800 699 ± 1226 0.077
Troponin T, ng/ml N/A 647 ± 610 583 ± 651 0.507
CPK, IU/l N/A 256 ± 197 2438 ± 3547 0.001
Hematocrit, % 42 ± 3 38 ± 5* 40 ± 3 0.554
Creatinine, μmol/l 82 ± 14 86 ± 53 50 ± 20* < 0.001
CRP mg/l 1.3 ± 1.3 36 ± 54* 15 ± 25* 0.093
Values are mean ± SD or n (%). *p < .05 compared to controls, p-values of the direct comparison between acute viral myocarditis and IIM myocarditis are shown in
the last column, using Mann-Whitney U or Fisher’s exact test, as appropriate
AV atrio-ventricular, IIM idiopathic inflammatory myopathy, BMI body-mass-index, CPK creatine phosphokinase, CRP c-reactive protein, NT-proBNP N-terminal pro
b-type natriuretic peptide
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(average of 57 months between diagnosis and CMR),
while patients with AVM had a shorter duration of dis-
ease (average 5 days between first onset of symptoms
and CMR). All IIM patients were under anti-
inflammatory and immunosuppressive treatment at the
time of CMR. CPK was elevated 10× in IIM patients
compared with the AVM patients while creatinine was
lower in the IIM group due to reduced muscle mass in
these patients (normal range 74-107 μmol/l). CRP and
NT-proBNP tended to be higher in the AVM group vs.
IIM patients although differences did not reach statis-
tical significance (Table 1).
Imaging characteristics
Biventricular volumes, functional parameters and strains
are reported in Table 2. LVand RV volumes and mass
were slightly higher in the AVM group and lower in the
IIM group. After age-adjustment, only LV end-systolic
volumes remained significantly higher and ejection frac-
tions significantly lower in AVM patients, while only RV
end-diastolic volumes remained significantly lower in
IIM patients. We found a markedly higher number of
patients with LGE, as well as a higher percentage of
LGE-positive segments in the AVM group as compared
with IIM patients. In addition, IIM patients showed LGE
in both epicardial and intramyocardial localizations,
while LGE in AVM patients was exclusively epicardial in
this study. No LGE was found in controls. While LV
global longitudinal strain differentiated controls from
IIM patients, no significant differences were found in
RV global longitudinal strain.
Differentiation of AVM and IIM myocarditis
Table 3 shows CMR mapping parameters in the myocar-
dium and in thoracic skeletal muscles. While none of
the myocardial mapping parameters was able to differen-
tiate AVM and IIM, irrespective of the inclusion or ex-
clusion of LGE, all skeletal muscle mapping parameters
significantly differentiated AVM from IIM. Of note,
myocardial mapping parameters significantly separated
controls from both groups of patients, even if LGE-
positive segments were excluded. These differences
remained significant after adjustment for age. Examples
of myocardial T1/T2 mapping images in the three
groups are shown in Fig. 2.
Figure 3 shows ROC curves illustrating the ability of
skeletal muscles and myocardium mapping parameters
to differentiate IIM from AVM. While skeletal muscle
post contrast T1 and ECV performed very well as
indicated by a high AUC (0.95 and 0.96 respectively), na-
tive T1 and T2 were less useful (AUC 0.79 and 0.81 re-
spectively). In contrast, myocardial mapping parameters
were unable to differentiate AVM from IIM (AUC 0.54
and 0.63 respectively). The cutoffs in this study for the
Table 2 CMR Imaging Parameters: ventricular geometry, strain and LGE
Healthy controls
(n = 20)
Acute viral myocarditis
(n = 20)
IIM with inflammatory
myocarditis
(n = 20)
P-value / age adjusted
p-value
LV
- EDV index, ml/m2 79 ± 16 85 ± 12 78 ± 15 0.059
- ESV index, ml/m2 32 ± 6 40 ± 8*/* 35 ± 13 0.038 / 0.329
- Mass index, ml/m2 54 ± 11 60 ± 10 55 ± 14 0.099
- EF, % 59 ± 4 53 ± 9*/* 56 ± 10 0.198
- GLS, % −25 ± 3 −24 ± 5 −23 ± 6* 0.235
RV
- EDV index, ml/m2 98 ± 21 99 ± 21 82 ± 19*/* 0.004 / 0.036
- ESV index, ml/m2 48 ± 14 50 ± 11 40 ± 19* 0.010 / 0.091
- EF, % 51 ± 7 49 ± 4 53 ± 12 0.026 / 0.396
- GLS, % −32 ± 8 −32 ± 7 −33 ± 9 0.659
LGE
LGE positive patients 0/20 (0%) 20/20 (100%)* 7/20 (35%)* < 0.001
Subepicardial LGE positive segments 0/340 (0%) 106/340 9/340 (5%)* < 0.001
Intramural LGE positive segments 0/340 (0%) (31%)* 9/340 (3%)* 0.004
Subendocardial LGE positive segments 0/340 (0%) 0/340 (0%) 0/340 (0%)
Values are mean ± SD or n / total (%). */* p < .05 compared to controls without / with age adjustment. p-values/age adjusted p-values of the direct comparison
between acute viral myocarditis and IIM myocarditis are shown in the last column, using Mann-Whitney U and a multivariate regression model or Fisher’s exact
test, as appropriate. Age adjusted p-values were calculated in case of significant non-adjusted p-values
IIM idiopathic inflammatory myopathy, LV left ventricular, EDV end-diastolic volume, ESV end-systolic volume, EF ejection fraction, GLS global longitudinal strain
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detection of myocardial inflammation were > 988 ms for
native T1 and > 50 ms for T2, while in the thoracic skel-
etal muscles, inflammation was best identified with a
cutoff of < 431 ms for post contrast T1 and ECV > 12%.
Comparison of CMR mapping parameters in different
muscle groups
Different thoracic muscle groups had similar mapping
parameters in healthy controls (Fig. 4), except for native
T1, with slightly lower values in the pectoralis major
and upper arm muscles and slightly higher values in the
subscapularis muscle. The other parameters showed very
comparable and robust normal values in all muscles
measured in the CMR field of view without significant
differences.
Discussion
This study shows that CMR T1 mapping allows identifi-
cation of myocardial involvement in IIM without signifi-
cant differences in myocardial mapping parameters
between IIM and AVM. In addition, in unclear cases of
suspected myocarditis and CMR with no or few areas of
LGE or presence of concomitant muscle weakness, dys-
pnea or dysphagia, T1 mapping in skeletal thoracic
muscle – particularly post contrast T1 and ECV – allow
reliable differentiation of acute viral myocarditis and IIM
inflammatory myocarditis. To our knowledge, no study
had yet compared AVM and IIM myocarditis using both
myocardial and skeletal muscle T1 mapping. Yao et al.
[18] showed that T2 mapping in muscles of the thigh in
IIM patients correlated to clinical severity scores and re-
ported mean T2 values of 60 ms. These T2 values are
slightly higher than the ones measured in IIM patients
in our study, which might be explained by differences in
T2 mapping sequences.
A large number of LGE positive segments were found
in the AVM group, corresponding to regions with a high
degree of myocardial inflammation and edema. IIM
patients also had LGE but less frequently than AVM pa-
tients and less frequently in the epicardial layer. Whole
heart T1 and T2 mapping parameters were not signifi-
cantly different between AVM and IIM. However, there
was a tendency for higher native T1 in AVM compared
with IIM, when LGE positive segments were included, as
LGE positive segments are known to result in higher na-
tive T1 values compared to LGE-negative segments [21].
Our findings indicate that both AVM and IIM had simi-
lar degrees of diffuse myocardial inflammation. Using
Lake Louise criteria with LGE as one of the diagnostic
criteria for AVM, cases of AVM without LGE might be
underdiagnosed to a certain degree in CMR. In relation
to our findings, false positives for cardiac involvement
may be even more of an issue if such diagnostic criteria
are used in the IIM setting. A more widespread use of
T1/T2 mapping in clinical routine could help alleviate
this issue. Cardiac volumes and mass were higher in the
AVM group as compared with the IIM group, which
might reflect younger, predominantly male AVM
Table 3 CMR Mapping Parameters
Healthy controls
(n = 20)
Acute viral myocarditis
(n = 20)
IIM with inflammatory myocarditis
(n = 20)
p-value / age adjusted
p-value
Myocardium including LGE positive segments
T1 native, ms 965 ± 25 1044 ± 63*/* 1017 ± 43*/* 0.121
T1 contrast 15 min, ms 379 ± 54 320 ± 34*/* 326 ± 54*/* 0.925
ECV, % 22 ± 3 24 ± 7*/* 23 ± 3 0.134
T2, ms 48 ± 2 53 ± 4*/* 53 ± 3*/* 0.758
Myocardium excluding LGE positive segment
T1 native, ms 965 ± 25 1023 ± 52*/* 1011 ± 36*/* 0.445
T1 contrast 15 min, ms 379 ± 54 330 ± 38*/* 328 ± 51*/* 0.718
ECV, % 22 ± 3 25 ± 3*/* 23 ± 4 0.351
T2, ms 48 ± 2 51 ± 3*/* 52 ± 3*/* 0.174
Skeletal Muscles
T1 native, ms 842 ± 39 844 ± 62 963 ± 127*/* 0.001 / 0.002
T1 contrast 15 min, ms 510 ± 43 482 ± 39*/* 374 ± 55*/* < 0.001 / < 0.001
ECV, % 10 ± 2 10 ± 3 19 ± 7*/* < 0.001 / < 0.001
T2, ms 40 ± 2 38 ± 2* 45 ± 10 < 0.001 / 0.022
Values are mean ± SD. */* p < .05 compared to controls without / with age adjustment. p-values/age adjusted p-values of the direct comparison between acute
viral myocarditis and IIM myocarditis are shown in the last column, using Mann-Whitney U test and a multivariate regression model. Age adjusted p-values were
only calculated in case of significant non-adjusted p-values
IIM idiopathic inflammatory myopathy, ECV extracellular volume fraction, SD Standard deviation
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patients compared to probably physically less active IIM
patients. Global myocardial strain did not discriminate
the two patient groups. Interestingly, all calculated map-
ping parameters performed very well to differentiate
both patient groups from healthy controls, irrespective
of the presence of LGE. These findings are in agreement
with other T1 mapping studies in AVM patients [14].
Up to our knowledge, the only T1 mapping study to date
in IIM with cardiac involvement is one case report
showing elevated native T1, ECV and T2 in a patient
with antisynthetase syndrome [16].
In addition to IIM, there are other systemic auto-
immune diseases with cardiac involvement, such as sys-
temic lupus erythematosus (SLE), sarcoidosis or systemic
sclerosis. Native T1 and T2 mapping techniques are able
to identify SLE patients from healthy controls [22], which
may be useful to detect subclinical myocardial
involvement in SLE [23]. Native T1 and ECV are also sig-
nificantly elevated in sarcoidosis patients without LGE
compared to healthy controls, albeit with a notable over-
lap between the two groups, making the diagnosis of car-
diac involvement challenging in the absence of LGE [24].
Myocarditis is also a common finding in SSc, and un-
treated systemic sclerosis results in myocardial remodeling
and fibrosis, as proven by endomyocardial biopsies [25].
Barison et al. [26] showed higher ECV in skeletal muscles
of systemic sclerosis patients compared to controls, con-
sistent with extracellular inflammation and remodeling.
Further studies combining analysis of myocardial and
skeletal muscle relaxation times over the time course of
the disease including active and remission phases may
help to better characterize such diseases. In addition,
AVM associated with skeletal muscle myositis has been
reported in cases of influenza B virus infection [27, 28].
Fig. 2 Myocardial T1 and T2 mapping and late gadolinium enhancement (LGE) images. Examples of myocardial T1 mapping in a healthy control
subject (female, 33 years old), a patient with AVM (acute viral myocarditis, female, 51 years old) and a patient with IIM (idiopathic inflammatory
myositis with cardiac involvement, male, 51 years old). On the first row, native T1 maps are shown (949 ms in the healthy control, 1019 ms in the
AVM patient and 1001 ms in the IIM patient. On the second row, post contrast T1 times were measured 332 ms, 277 ms and 306 ms. On the
third row, T2 relaxation times were measured 45 ms, 52 ms and 50 ms. Corresponding late gadolinium slices are shown on the last row with
slight inferior and infero-lateral sub-epicardial enhancement in the AVM patient, while a minimal infero-lateral subepicardial enhancement can be
discussed in the IIM patient. Post contrast T1 in the pectoralis muscle was 469 ms, 499 ms and 399 ms, thus differentiating the IIM patient from
the AVM patient and the healthy control
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Fig. 3 ROC curves illustrating the ability of thoracic skeletal muscles and myocardium mapping parameters to differentiate acute viral myocarditis
(AVM) from idiopathic inflammatory myopathy (IIM) myocarditis patients. Area under the ROC curve (AUC) for each mapping parameter are
indicated, as well as optimized cutoff values with corresponding sensitivities, specificities and accuracies. ECV = extracellular volume fraction, %
Fig. 4 Comparison of different CMR mapping parameters for the measured muscle groups in healthy controls. Error bars indicate 95%-confidence-interval.
P-value of Kruskal-Wallis test between muscle groups is indicated for each mapping parameter. ECV = extracellular volume fraction, %
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However, there are no available data on the combination
of myocardial and skeletal muscle T1- and ECV-mapping
in such patients necessary to gain more insight into the
complex relationship between systemic infection and con-
comitant myocardial and skeletal muscle inflammation.
Native T1 was significantly different between the skel-
etal muscle groups, especially in the more peripherally
located pectoralis and upper arm muscles. This may
have explanations. First, CMR is focused on the heart,
using a thoracic coil, and shimming will be less opti-
mized in the periphery of the CMR field-of view. In
addition, T1 shortening due to susceptibility might
occur, especially in locations close to air near the body
surface. Also, possible spill in from peri-muscular fat
might occur in patients with thin muscles, affecting es-
pecially the pectoralis muscle due to its anatomic
localization. These effects may be further aggravated by
motion artefacts. Pectoralis muscles may be affected
both by breathing and arm movement. Due to shortened
T1 after gadolinium injection and due to relative com-
pensation in the ECV formula (ratio), post contrast T1,
and ECV were less sensitive to these effects. This may
be similar for T2 with refocusing pulses in the SSFP-based
sequence. However, post contrast T1, T2 and ECV in dif-
ferent thoracic skeletal muscle groups showed comparable
values in healthy controls. Thus, all of the measured mus-
cles can be used for measuring skeletal muscle relaxation
time, as visualized on any standard CMR field of view.
With these considerations kept in mind and for simplicity,
post contrast T1, T2 and ECV may be measured in the
best visualized muscle allowing to place the largest ROI
excluding vessels, tendons and fat.
A schematic clinical flow-chart on how mapping tech-
niques might be used in patients with suspected AVM/
IIM is proposed in Fig. 5. It should be noted that map-
ping parameter cutoff values relative to this proof-of-
concept study are presented but may not be extrapolated
as such to other settings and centers due to important
mapping parameter variability as highlighted in recent
guidelines [29]. Although IIM-related myocarditis is rare
compared to AVM, IIM patients with cardiac involve-
ment need early diagnosis and management, since they
have a significantly higher mortality rate compared with
IIM patients without cardiac involvement (p < 0.001) in
longitudinal studies [2]. Consequently, these patients
may require intensified immunosuppression [8] unlike
Fig. 5 Schematic workflow in patients undergoing CMR for suspected myocarditis. The cutoffs in this study for myocardial inflammation were
> 988 ms for native T1 and > 50 ms for T2 in the myocardium, while in the thoracic skeletal muscles, inflammation was best identified with a
cutoff of < 431 ms for post contrast T1 and an ECV > 12%. Please note that cutoffs for mapping parameters might significantly vary between centers
with different vendors, field strengths and acquisition parameters, so identification of normal values in healthy volunteers is recommended for each
CMR magnet [29]. CMR = cardiovascular magnetic resonance; ECV = extracellular volume fraction; IIM = idiopathic inflammatory myopathy
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AVM patients undergoing more conservative treatment
and supportive care [30]. Whether early treatment
strategies based on CMR detection of cardiac involve-
ment may improve the prognosis of IIM patients is un-
known and warrants further investigation. In addition,
further studies should evaluate the utility of T1 and T2
mapping in the skeletal muscle in other systemic dis-
eases such as sarcoidosis, SLE and systemic sclerosis
patients.
This study has several limitations. There is a relatively
small patient population given the difficulty to recruit
IIM patients with elevated cardiac troponins and CMR.
Nevertheless, differentiation of acute viral and IIM myo-
carditis was highly significant using skeletal muscle map-
ping. Endomyocardial biopsy is not routinely performed
in patients with non-complicated myocarditis in our
center. In addition, even if all IIM patients had diagnosis
proven by skeletal muscle biopsy and histology, there
was no such data in the AVM group as there was no in-
dication for biopsy of skeletal muscles in this group. An-
other limitation is that shimming is not optimized for
skeletal muscles in typical CMR exams, potentially af-
fecting native T1 to a higher degree than post contrast
T1, ECV and T2 as discussed above. However, the latter
three parameters did not differ significantly between dif-
ferent thoracic skeletal muscle groups when peri-muscular
fat and intra-muscular tendons were carefully excluded.
Conclusion
A combined investigation of myocardial and skeletal muscle
CMR T1 mapping parameters allow accurate differentiation
of AVM from IIM myocarditis by measuring post contrast
T1 and ECV in the skeletal muscle. This approach could
help in identifying patients with IIM-related cardiac in-
volvement in patients referred to CMR for suspected AVM,
allowing differential diagnosis, early IIM treatment and po-
tentially lead to improved patient outcome.
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